Navigation Links
Pressure BioSciences, Inc. to Discuss First Quarter 2012 Financial Results And Provide Business Update
Date:5/15/2012

SOUTH EASTON, Mass., May 15, 2012 /PRNewswire/ -- Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and the "Company") today announced that the Company will host a teleconference to discuss its First Quarter 2012 financial results and to provide a business update.  Anyone interested may listen to the teleconference either by telephone or through a live web-cast.  The teleconference and web-cast information is provided below:

Date:  Wednesday, May 16, 2012
Time: 4:15 p.m. Eastern Daylight Time (EDT)

To attend this teleconference via web-cast, please visit the Company's website:
www.pressurebiosciences.com

To attend this teleconference via telephone:
Dial-in: (888) 383-9147

For those unable to participate in the live teleconference, a replay will be available approximately one hour after the call ends through June 16, 2012, and will be accessible through the Company's website. 

About Pressure BioSciences, Inc.

Pressure BioSciences, Inc. ("PBI") (OTCQB: PBIO) is focused on the development, marketing, and sale of proprietary laboratory instrumentation and associated consumables based on Pressure Cycling Technology ("PCT").  PCT is a patented, enabling technology platform with multiple applications in the estimated $6 billion life sciences sample preparation market.  PCT uses cycles of hydrostatic pressure between ambient and ultra-high levels to control bio-molecular interactions.  PBI currently focuses its efforts on the development and sale of PCT-enhanced sample preparation systems (instruments and consumables) for mass spectrometry, biomarker discovery, bio-therapeutics characterization, vaccine development, soil and plant biology, forensics, histology, and counter-bioterror applications.

Investor Contacts:
Pressure BioSciences, Inc.
Richard T. Schumacher, President & CEO
Joseph Damasio, Jr., VP of Finance & Administration
(
T) 508-230-1828


'/>"/>
SOURCE Pressure BioSciences, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Failure to Take Medicine Linked to Unnecessary Hospital Visits, Especially for Medicare Patients Taking High Blood Pressure or High Cholesterol Medications
2. Pressure BioSciences, Inc. and Target Discovery, Inc. Expand Strategic License Agreement and Collaboration Supporting TDIs Planned Offering of Personalized Medicine Clinical Diagnostic Services
3. Europe Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multiparameter Patient Monitoring, Neonatal Monitors, Non-Invasive Blood Pressure Monitors, Remote Patient Monitoring and Others
4. North America Patient Monitoring Market Outlook to 2017 - Fetal Monitors, Multiparameter Patient Monitoring, Neonatal Monitors, Non-Invasive Blood Pressure Monitors, Remote Patient Monitoring and Others
5. Femasys Receives FDA 510(k) Clearance for First Low Pressure HSG Device
6. ICU Medical Launches Neutron™ Needlefree Catheter Patency Device With Constant Neutral Pressure Backed by a $100,000 Guarantee to Reduce Catheter Occlusions
7. Top 20 Contract Research Organizations (CRO) - Asia-Pacific, Especially India and China, Positioned to Benefit from Rising Financial and Regulatory Pressures in Western Pharmaceutical Markets
8. iHealth Labs Blood Pressure Self-Monitoring System Gets Nationwide Distribution
9. FDA: Treatment With Angiotensin Receptor Blockers for High Blood Pressure Does Not Increase Risk of Cancer
10. HERCULES Trial Demonstrates Significant Reduction in Systolic Blood Pressure While Revealing Marker in Hypertensive Patients Does Not Predict Outcomes of Renal Artery Stenting
11. Wellsense Unveils First-Ever Bedside Patient Pressure Mapping System Designed to Assist Caregivers in Effectively Repositioning Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2016)... , Dec. 6, 2016  Nearly 30 million people ... from the epidemic of diabetes. 1 However, nearly ... elevated glucose levels (hyperglycemia) and significant glucose variability. 2 ... complications, including cardiovascular events. If left untreated, hyperglycemia can ... eye disease or blindness. 3 As ...
(Date:12/6/2016)... -- With opioids commonly used for pain management for workplace injuries, ... has led to nationwide fatalities. The synthetic opioid called ... heroin or morphine, resulting in likelihood of addiction, abuse or death. ... , , ... Behavioral Health for HMC HealthWorks, explained the opioid drug is less ...
(Date:12/6/2016)... -- Blueprint Medicines Corporation (NASDAQ: BPMC ), a ... patients with genomically defined diseases, today announced that it ... in shares of its common stock. In addition, Blueprint ... to purchase up to an additional of $18,750,000 million ... the public offering. All shares of common stock will ...
Breaking Medicine Technology:
(Date:12/7/2016)... ... December 07, 2016 , ... The ... offices located in South Lyon, Dewitt, Williamston, East Lansing, Ann Arbor, and Farmington ... needs treatment for a brain tumor. , Jason Bauer and his family are ...
(Date:12/7/2016)... Queens, NY (PRWEB) , ... December 07, 2016 , ... ... to business owners and families throughout the Five Boroughs, is launching a charity drive ... League works to continue the traditions and spirit of marines and Navy FMF Corpsmen. ...
(Date:12/7/2016)... (PRWEB) , ... December 07, 2016 , ... Delete® - ... in Time For The Holiday Party Season. Save Up To 33% Off Botox® and ... Salon is providing the Phoenix Valley with Delightful Deals on Botox® and ...
(Date:12/7/2016)... CINCINNATI, Ohio (PRWEB) , ... December 07, 2016 ... ... winner in the 2016 BOC Business Brilliance Awards under the Best New Product ... inception and results achieved through user experience. , BOC Global Events & Training ...
(Date:12/7/2016)... ... ... “Walking With God: Inspirational Lessons from My Life's Journey”: a sometimes ... of God's direction in their lives. “Walking With God: Inspirational Lessons from My Life's ... leader. , Sanford says, “I enjoy sharing the true stories in my ...
Breaking Medicine News(10 mins):